Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Burning Rock Biotech (BNR) over the last 4 years, with Dec 2024 value amounting to $12.0 million.

  • Burning Rock Biotech's Shares Outstanding (Diluted Average) rose 5.95% to $90.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $90.3 million, marking a year-over-year increase of 5.95%. This contributed to the annual value of $12.0 million for FY2024, which is 0.53% down from last year.
  • Burning Rock Biotech's Shares Outstanding (Diluted Average) amounted to $12.0 million in FY2024, which was down 0.53% from $12.0 million recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Shares Outstanding (Diluted Average) peaked at $13.5 million during FY2021, and registered a low of $12.0 million during FY2024.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $12.0 million (2023), whereas its average is $12.3 million.
  • Data for Burning Rock Biotech's Shares Outstanding (Diluted Average) shows a maximum YoY fell of 6.65% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Burning Rock Biotech's Shares Outstanding (Diluted Average) stood at $13.5 million in 2021, then fell by 4.53% to $12.9 million in 2022, then fell by 6.65% to $12.0 million in 2023, then fell by 0.53% to $12.0 million in 2024.